tiprankstipranks
Trending News
More News >
HBM Holdings Ltd. (HK:2142)
:2142
Hong Kong Market
Advertisement

HBM Holdings Ltd. (2142) Similar Stocks

Compare
4 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
HBM Holdings Ltd.
HK$9.02
HK$7.54B
311.03
593.85%
0 Buy
0 Hold
0 Sell
Hold
Alphamab Oncology
HK$9.43
HK$9.19B
50.27
324.77%
Lepu Biopharma Co. Ltd. Class H
HK$7.95
HK$14.78B
154.81%
Abbisko Cayman Limited
HK$10.16
HK$6.91B
173.08
270.80%
0 Buy
0 Hold
0 Sell
Hold
CStone Pharmaceuticals
HK$6.74
HK$9.72B
443.55%
1 Buy
0 Hold
0 Sell
Moderate Buy
Shandong Boan Biotechnology Company., Limited. Class H
HK$16.42
HK$9.43B
106.28
76.94%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
HK:2142
HBM Holdings Ltd.
9.02
7.72
593.85%
HK:9966
Alphamab Oncology
9.43
7.21
324.77%
HK:2157
Lepu Biopharma Co. Ltd. Class H
7.95
4.83
154.81%
HK:2256
Abbisko Cayman Limited
10.16
7.42
270.80%
HK:2616
CStone Pharmaceuticals
6.74
5.50
443.55%
HK:6955
Shandong Boan Biotechnology Company., Limited. Class H
16.42
7.14
76.94%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis